DL, L., RLM, B., LFAG, M., WJG, M., AG, S., & J, B. (2019). Justifying conservative management of CIN2 in women younger than 25 years - A population-based study. Gynecologic oncology, 152(1), 82. https://doi.org/10.1016/j.ygyno.2018.10.038
Chicago Style (17th ed.) CitationDL, Loopik, Bekkers RLM, Massuger LFAG, Melchers WJG, Siebers AG, and Bentley J. "Justifying Conservative Management of CIN2 in Women Younger than 25 years - A Population-based Study." Gynecologic Oncology 152, no. 1 (2019): 82. https://doi.org/10.1016/j.ygyno.2018.10.038.
MLA (9th ed.) CitationDL, Loopik, et al. "Justifying Conservative Management of CIN2 in Women Younger than 25 years - A Population-based Study." Gynecologic Oncology, vol. 152, no. 1, 2019, p. 82, https://doi.org/10.1016/j.ygyno.2018.10.038.